Effectiveness and safety of a thermo-mechanical action device versus thermal pulsation device in the treatment of meibomian gland dysfunction
TMA safely and effectively improved clinical signs and symptoms of evaporative dry eye disease associated with MGD over a 12-week period, comparable to TP.
Authors
- Ehsan Sadri (ORCID: https://orcid.org/0000-0003-3823-6791)
- Gregg J. Berdy (ORCID: https://orcid.org/0009-0000-3041-9951)
- Anthony Verachtert
- Julio Echegoyen
- Ifat Klein
- Yael G. Agmon
- Gregory Parkhurst (ORCID: https://orcid.org/0000-0002-9946-8724)
Institutions
- Visionary Pharmaceuticals (United States) (US)
- Gordon Schanzlin New Vision Institute (US)
- Tauber Eye Center (US)
- Ophthalmology Associates (United States) (US)
Publication Details
- Journal
- Journal of Cataract & Refractive Surgery
- Published
- 2024-12-16
- DOI
- https://doi.org/10.1097/j.jcrs.0000000000001602
- Citations
- 5
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 2.71